We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
$50 for your first 3 months Get the print edition and steer from crisis to recovery
Add this topic to your myFT Digest for news straight to your inbox
Decision could pave the way for US authorisation of first single-dose jab
FDA report finds single-dose shot effective in preventing severe symptoms in US, Brazil and South Africa
FDA says companies could avoid lengthy trials to speed up authorisation of tweaked jabs
FDA will now weigh whether to allow use of first single-dose jab to prevent the virus
FDA veteran Janet Woodcock oversaw approval of new painkillers amid worsening epidemic
US agency go-ahead will provide boost to supplies as hospitalisations due to pandemic soar
FDA emergency authorisation will make US the first country to greenlight a second jab
US regulator expected to grant emergency authorisation for inoculation by end of week
Self-testing kit developed by Australia’s Ellume provides results in 20 minutes
FDA staff report paves the way for possible approval by end of the week
Food and Drug Administration head denies yielding to White House pressure
FDA poised for final decision after receiving endorsement from advisory committee
Trump ‘very hopeful’ regulators will grant emergency approval in US ‘within days’
Regulators on both sides of Atlantic set to decide on approval in coming weeks
The FDA issues emergency use authorisation for Regeneron’s antibody treatment
US FDA gives emergency approval to bamlanivimab therapy designed to boost immune system
Scientists express scepticism of trial data and US regulatory process at fiery hearing
President hits out at FDA over approval process in latest fight with scientific advisers
Europe readies rolling reviews of potential jabs as US broadens inquiry into adverse reaction
Guidelines agreed with pharmaceuticals companies make pre-election jab unlikely
Fauci and Redfield push back on Trump’s more optimistic projections at Senate hearing
Stricter FDA guidelines make it unlikely one will be approved before November election
Experts fear damage to public trust as tests remain on hold in US but restart elsewhere
National Institutes of Health panel says ‘insufficient’ evidence to back treatment touted by Trump
International Edition
